The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Fosters I think many shares are out of favours. Seem many people have lost the faith in buying shares at the moment which includes BMN.
The danger of announcing news at the moment is that we may not get the re-rate we desire. Let’s hope there’s positive results for now before any VRFB news.
Even Bitcoin has plunged massively today-a lot of money being drawdown as everyone panics with rising costs and negative portfolios.
I just feel grateful to be able to buys shares and have a regular income to let the storm pass without panic selling anything.
Yes CC, like a normal worker is going to be able to calculate and then complain about being robbed of 1-2% after seeing their wage increase 6% every year. I've been contracted to the NHS and seen my pay take a 30-40% hit over 10 years without complaint. We would have been sipping champagne at such an agreement.
You really have a real mistrust of South Africans and I called you out for this last time with your comments.
With the expansion run rate confirmed and Cellcube being listed , you'd expect BMN to get closer to Largos valuation . Even 2/3's would make BMN's market cap fairer.
Only Dan can save us. Riddell obviously wasn’t cut out for finding a CEO or Taking us forward so hope he enjoys his new role.
Doesn’t look good but I will have to see it out until the end.
If you don’t laugh you would cry as I had a decent profit at one point few years ago. Will keep this quiet from the mrs Incase it can turn around by a miracle :)
Agree its not over for NXP002 but the timeline is getting longer and longer and the hopes of somebody taking a punt on it is drifting.
My hope as with Olderandwiser is that NXP004 becomes something that can easily be sold to the market this year and we are not reliant on NXP002 due to the wait required for the CRO and reformulation.
It's a shame Anne left when she did, she probably had the contacts and the acumen to move to a different CRO and obtain the results required sooner.
I hope we go full tilt on NXP004 now before we have time to even bother with NXP002.